Literature DB >> 18400180

Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex.

Jacky Chi Ki Ngo1, Mingdong Huang, David A Roth, Barbara C Furie, Bruce Furie.   

Abstract

Factor VIII is a procofactor that plays a critical role in blood coagulation, and is missing or defective in hemophilia A. We determined the X-ray crystal structure of B domain-deleted human factor VIII. This protein is composed of five globular domains and contains one Ca(2+) and two Cu(2+) ions. The three homologous A domains form a triangular heterotrimer where the A1 and A3 domains serve as the base and interact with the C2 and C1 domains, respectively. The structurally homologous C1 and C2 domains reveal membrane binding features. Based on biochemical studies, a model of the factor IXa-factor VIIIa complex was constructed by in silico docking. Factor IXa wraps across the side of factor VIII, and an extended interface spans the factor VIII heavy and light chains. This model provides insight into the activation of factor VIII and the interaction of factor VIIIa with factor IXa on the membrane surface.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18400180     DOI: 10.1016/j.str.2008.03.001

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  84 in total

1.  Structural insights into the interaction of blood coagulation co-factor VIIIa with factor IXa: a computational protein-protein docking and molecular dynamics refinement study.

Authors:  Divi Venkateswarlu
Journal:  Biochem Biophys Res Commun       Date:  2014-08-23       Impact factor: 3.575

2.  A3 domain region 1803-1818 contributes to the stability of activated factor VIII and includes a binding site for activated factor IX.

Authors:  Esther Bloem; Henriet Meems; Maartje van den Biggelaar; Koen Mertens; Alexander B Meijer
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

3.  Identification of residues in the 558-loop of factor VIIIa A2 subunit that interact with factor IXa.

Authors:  Indu Jagannathan; H Travis Ichikawa; Tricia Kruger; Philip J Fay
Journal:  J Biol Chem       Date:  2009-09-28       Impact factor: 5.157

4.  Role of hydrophobic mutations on the binding affinity and stability of blood coagulation factor VIIIa: a computational molecular dynamics and free-energy analysis.

Authors:  Divi Venkateswarlu
Journal:  Biochem Biophys Res Commun       Date:  2014-06-18       Impact factor: 3.575

5.  Contribution of factor VIII light-chain residues 2007-2016 to an activated protein C-interactive site.

Authors:  Masahiro Takeyama; Hironao Wakabayashi; Philip J Fay
Journal:  Thromb Haemost       Date:  2012-12-06       Impact factor: 5.249

6.  Factor VIIIa A2 subunit shows a high affinity interaction with factor IXa: contribution of A2 subunit residues 707-714 to the interaction with factor IXa.

Authors:  Amy E Griffiths; Ivan Rydkin; Philip J Fay
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

7.  Trp2313-His2315 of factor VIII C2 domain is involved in membrane binding: structure of a complex between the C2 domain and an inhibitor of membrane binding.

Authors:  Zhuo Liu; Lin Lin; Cai Yuan; Gerry A F Nicolaes; Liqing Chen; Edward J Meehan; Bruce Furie; Barbara Furie; Mingdong Huang
Journal:  J Biol Chem       Date:  2010-01-20       Impact factor: 5.157

8.  Domain organization of membrane-bound factor VIII.

Authors:  Svetla Stoilova-McPhie; Gillian C Lynch; Steven Ludtke; B Montgomery Pettitt
Journal:  Biopolymers       Date:  2013-07       Impact factor: 2.505

Review 9.  B-cell and T-cell epitopes in anti-factor VIII immune responses.

Authors:  Kathleen P Pratt; Arthur R Thompson
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

10.  Molecular orientation of factor VIIIa on the phospholipid membrane surface determined by fluorescence resonance energy transfer.

Authors:  Hironao Wakabayashi; Philip J Fay
Journal:  Biochem J       Date:  2013-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.